ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$0.12
-0.02 (-15.69%)
As of Mar 31, 5:00 PM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +29,350.8% upside
Low Target $28.98
Average Target $35.93
High Target $50.96
Current Price $0.12
Current
$0.12
Target
$35.93
$28.98 $35.93 avg $50.96
Scenario Analysis
Bear Case
$28.98
23,654.1%
Low target
Base Case
$35.93
+29,350.8%
Avg target
Bull Case
$50.96
+41,670.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$35.93
+144.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%